OncBioMune Pharmaceuticals, Inc. Email Format

BiotechnologyLouisiana, United States2-10 Employees

OncBioMune Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on cancer therapies, developing immunotherapy products and targeted cancer treatments. It uses a proprietary Vaccine Technology designed to stimulate the immune system to attack cancer cells while aiming to spare patients from undue harm. The lead product, ProscaVax, was positioned to enter Phase 2 in early 2016, and the company also maintains a portfolio that includes targeted therapies, some of which are biosimilars to established drugs. The company is headquartered in Baton Rouge, Louisiana, and operates with a small team. 

In the biotechnology research landscape, OncBioMune is positioned as a developer of immunotherapy approaches for cancer and a portfolio of targeted modalities. A notable 2020 development involved completing the asset purchase of Avant Diagnostics and subsequently changing the corporate name to Theralink Technologies Inc., reflecting a strategic corporate pivot.

Sign up for free to view info

Company overview Employee directory